title: Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Casey
authors.forename: Dan W
authors.initials: DW
authors.lastname: Haupt
authors.forename: John W
authors.initials: JW
authors.lastname: Newcomer
authors.forename: David C
authors.initials: DC
authors.lastname: Henderson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Sernyak
authors.forename: Michael
authors.initials: M
authors.lastname: Davidson
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Lindenmayer
authors.forename: Steven V
authors.initials: SV
authors.lastname: Manoukian
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Banerji
authors.forename: Harold E
authors.initials: HE
authors.lastname: Lebovitz
authors.forename: Charles H
authors.initials: CH
authors.lastname: Hennekens
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D002423:Cause of Death; D016883:Diabetic Ketoacidosis / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality; D009203:Myocardial Infarction / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D009765:Obesity / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality; D015995:Prevalence; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy* / Q000401:mortality*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents